The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors
Part of paid clinical trials in Aurora, Colorado.
- Sponsor
- University of Colorado, Denver
- Study ID
- NCT01201850
- Status
- Terminated
Conditions
- Radiation Necrosis
Eligibility Criteria
- Sex
- ALL
- Age
- 1 Year - 25 Years
- Healthy Volunteers
- Not accepted
Interventions
- Bevacizumab (Avastin®) — DRUGOnce enrolled on study, patients will be treated with bevacizumab (10mg/kg) intravenously (i.v.) every 2 weeks for a total of 6 doses. An MRI will be done after the first cycle (3 doses/ 6weeks) and then again at the end of therapy.
Study Details
This study is being done to learn about the safety of the study drug bevacizumab(Avastin®), when used to treat radiation necrosis. The primary objective of this study is to test the feasibility of treating Central Nervous System (CNS) tumor patients suffering from radiation necrosis with bevacizumab every 2 weeks. The secondary objectives of this study are: * To evaluate improvement in neurologic symptoms associated with bevacizumab as assessed by clinical evaluation; * To investigate the neuro-imaging changes in radiation necrosis associated edema, including Mass Resonance (MR) spectroscopy; * To evaluate changes in corticosteroid use in patients with radiation necrosis following treatment with bevacizumab; * To evaluate changes in quality of life.
Key Dates
- First listed
- Sep 15, 2010
- Start date
- Jun 28, 2010
- Status verified
- Apr 2021
- Primary completion
- Aug 4, 2016
- Completion
- Aug 4, 2016
Study Design
- Enrollment
- 7 participants (actual)
- Allocation
- NA
- Intervention model
- SINGLE_GROUP
- Primary purpose
- TREATMENT
Arms
- Experimental: Bevacizumab (Avastin®)Once enrolled on study, patients will be treated with bevacizumab (10mg/kg) intravenously (i.v.) every 2 weeks for a total of 6 doses.
Primary Outcome Measure
Number of Participants Who Received at Least 5 of the 6 Scheduled Doses of Bevacizumab [ Time Frame: 13 weeks ]
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Children's Hospital Colorado | Aurora | Colorado | 80045 | - |
Find similar trials in Aurora, CO
Related Studies
- REMASTer: REcurrent Brain Metastases After SRS TrialRecruiting · Monteris Medical · Los Angeles, California
- TENS of Auricular Vagal Nerve for Radiation NecrosisNot Yet Recruiting · Virginia Commonwealth University · Richmond, Virginia